A decade ago, voters in California changed the biomedical research landscape by directly funding embryonic stem-cell research. Now the organization they created needs a hit to survive.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea
Stem Cell Reviews and Reports Open Access 02 October 2015
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
11 July 2014
The time line in this feature wrongly identified Alan Trounson as the first president of the California Institute for Regenerative Medicine. He was, in fact, the second — he succeeded Zach Hall. This has now been corrected.
Electronic supplementary material
A vote for stem cells
Related links
Related links
Related links in Nature Research
Funding windfall rescues abandoned stem-cell trial 2014-Jun-03
Stem-cell agency faces budget dilemma 2012-Jan-31
Stem-cell boss urges communication 2011-Jun-29
Stem cells: The impatient advocate 2010-Dec-01
California stem-cell grants awarded 2009-Nov-02
Stem cells: The 3-billion-dollar question 2008-Apr-30
Related external links
Rights and permissions
About this article
Cite this article
Check Hayden, E. Stem cells: Hope on the line. Nature 511, 19–21 (2014). https://doi.org/10.1038/511019a
Published:
Issue date:
DOI: https://doi.org/10.1038/511019a
This article is cited by
-
Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea
Stem Cell Reviews and Reports (2016)
